KJZZ discussion of Alzheimer's Disease
Public-radio station KJZZ's "Here and Now" program on May 7 focused on Alzheimer's Disease. Host Steve Goldstein interviewed researcher Marwan Sabbagh, members of the Arizona Alzheimer's Consortium, and experts in family services and caregiving. Listen to the broadcast here.
 Picking Up Speed
2007 marked the halfway point in Arizona's 10-year push to strengthen its bioscience sector. This brochure highlights important data and key events signaling the state's progress in 2007 toward fulfilling the strategies of Arizona's Bioscience Roadmap.
 High School Bioscience Programs
How is Arizona preparing its future bioscience workforce? A new report provides a snapshot of high school bioscience education programs in Arizona. To download, click here. A brochure providing summary analysis and recommendations for improving bioscience education is available here.
 Arizona BioBasics
Your starting place on the Web for understanding the terms, organizations, and history of Arizona biosciences is now live. Check it out at http://www.arizonabiobasics.com.
|
Mayo Clinic cancer investigator builds prodigious research network
ASU appoints Biodesign director to lead new research effort
'Fund of funds' launched to build venture capital
|
07/17/2008 | The Arizona Economic Resource Organization (AERO), a nonprofit group created last year to coordinate the state's economic-development efforts, has received $325,000 to launch a "fund of funds" to commercialize high-technology innovations. The initiative's planners believe it could elicit $200 million in new venture-capital funding for Arizona-based entrepreneurs.

|
|
UA president announces restructuring of health-sciences areas
Governor signs budget preserving bioscience priorities
|
07/01/2008 | State bioscience interests achieved an escape worthy of Houdini in the Arizona Legislature's just-completed budget process. Early Friday, the Legislature passed a $9.9 billion budget for fiscal year 2009, which begins today, erasing a projected shortfall of $2 billion and leaving intact three of the funding priorities dearest to bioscience advocates.

|
|
|
|